We are live on ! Find out more
FCE

Fiera Capital (Europe) Portfolio holdings

AUM $213M
1-Year Est. Return 42.35%
This Fund
S&P 500
This Quarter Est. Return
-4.27%
1 Year Est. Return
+42.35%
3 Year Est. Return
+41.33%
5 Year Est. Return
10 Year Est. Return
AUM
$132M
AUM Growth
-$46.3M
Cap. Flow
-$36.4M
Cap. Flow %
-27.56%
Top 10 Hldgs %
80.05%
Holding
61
New
10
Increased
17
Reduced
23
Closed
8

Sector Composition

Rank Sector Weight
1 Consumer Staples 28.96%
2 Financials 22.33%
3 Communication Services 16.83%
4 Materials 9.65%
5 Energy 6.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
26
Bristol-Myers Squibb
BMY
$132B
$198K 0.15%
3,822
+1,122
+42% +$59.7K
OREX
27
DELISTED
Orexigen Therapeutics, Inc.
OREX
$182K 0.14%
+2,830
New +$191K
GILD icon
28
Gilead Sciences
GILD
$165B
$177K 0.13%
2,502
-501
-17% -$39.3K
VTRS icon
29
Viatris
VTRS
$18.9B
$170K 0.13%
3,485
+2,034
+140% +$98.8K
MDT icon
30
Medtronic
MDT
$112B
$167K 0.13%
2,718
+1,077
+66% +$62.7K
TMO icon
31
Thermo Fisher Scientific
TMO
$220B
$155K 0.12%
+1,286
New +$153K
MDVN
32
DELISTED
MEDIVATION, INC.
MDVN
$148K 0.11%
4,588
+3,586
+358% +$132K
ILMN icon
33
Illumina
ILMN
$28.4B
$142K 0.11%
979
SNY icon
34
Sanofi
SNY
$104B
$142K 0.11%
2,700
INVA icon
35
Innoviva
INVA
$1.48B
$140K 0.11%
5,401
+2,255
+72% +$66K
AMGN icon
36
Amgen
AMGN
$222B
$131K 0.1%
1,065
-315
-23% -$38.2K
FRX
37
DELISTED
FOREST LABORATORIES INC
FRX
$117K 0.09%
1,269
+157
+14% +$12.7K
SLXP
38
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$110K 0.08%
1,068
+698
+189% +$71.5K
NSTG
39
DELISTED
NanoString Technologies, Inc.
NSTG
$85K 0.06%
+4,081
New +$77.7K
BDX icon
40
Becton Dickinson
BDX
$48.2B
$82K 0.06%
+714
New +$78.5K
ABT icon
41
Abbott
ABT
$187B
$75K 0.06%
1,940
+267
+16% +$10.3K
BIIB icon
42
Biogen
BIIB
$30.7B
$72K 0.05%
236
-200
-46% -$63.5K
REGN icon
43
Regeneron Pharmaceuticals
REGN
$80.8B
$70K 0.05%
233
-92
-28% -$28.3K
NPSP
44
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$56K 0.04%
+1,876
New +$64.7K
ARWR icon
45
Arrowhead Research
ARWR
$12.4B
$54K 0.04%
3,305
-33,860
-91% -$595K
PCYC
46
DELISTED
PHARMACYCLICS INC
PCYC
$52K 0.04%
+519
New +$67.5K
CVD
47
DELISTED
COVANCE INC.
CVD
$50K 0.04%
842
+467
+125% +$46.3K
IQV icon
48
IQVIA
IQV
$39.3B
$49K 0.04%
973
+227
+30% +$11.4K
CELG
49
DELISTED
Celgene Corp
CELG
$49K 0.04%
696
-430
-38% -$34.1K
CBST
50
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$45K 0.03%
612
+135
+28% +$10.1K

Similar funds

Fiera Capital (Europe)'s Q1 2014 Portfolio in Review

As of Q1 2014, Fiera Capital (Europe) held 61 positions worth $132M, down 26% from $178M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Fiera Capital (Europe) withdrew a net $36.4M in Q1 2014, closing 8 positions and reducing 23 holdings. Its most notable exit was Banco Santander Chile, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 29% of assets, up from 22% a quarter earlier, followed by Financials and Communication Services.

Against the trend, Fiera Capital (Europe) opened a new position in AVIANCA HOLDINGS S.A. worth $1.71M.

  • Fiera Capital (Europe)'s largest Q1 2014 buy was AVIANCA HOLDINGS S.A.: 100,532 shares worth $1.71M.
  • Fiera Capital (Europe) added most to Fomento Económico Mexicano in Q1 2014, an estimated $2.27M increase.
  • Fiera Capital (Europe)'s biggest Q1 2014 reduction was Vale, cutting an estimated $4.6M.
  • Fiera Capital (Europe) fully exited Banco Santander Chile in Q1 2014, selling an estimated $12.3M.
  • Fiera Capital (Europe)'s ten largest holdings make up 80% of its $132M portfolio in Q1 2014.
  • Fiera Capital (Europe) opened 10 new positions and closed 8 in Q1 2014.
  • Fiera Capital (Europe)'s portfolio value fell 26% quarter-over-quarter to $132M.

Based on Fiera Capital (Europe)'s 13F filing for Q1 2014, filed 13 May 2014.